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ABSTRACT:
Breast cancer resistance protein (BCRP, ABCG2) is expressed in
the hepatic canalicular membrane and mediates biliary excretion of
xenobiotics including sulfate and glucuronide metabolites of some
compounds. Hepatic Bcrp expression is sex-dependent, with higher
expression in male mice. The hypothesis that sex-dependent Bcrp
expression influences the hepatobiliary disposition of phase II metab-
olites was tested in the present study using acetaminophen (APAP)
and the generated APAP glucuronide (AG) and sulfate (AS) metabo-
lites in single-pass in situ perfused livers from male and female wild-
type and Abcg/ (Bcrp-deficient) mice. Pharmacokinetic modeling
was used to estimate parameters governing the hepatobiliary dis-
position of APAP, AG, and AS. In wild-type mice, the biliary excretion
rate constant was 2.5- and 7-fold higher in males than in females for
AS and AG, respectively, reflecting male-predominant Bcrp expres-
sion. Sex-dependent differences in AG biliary excretion were not
observed in Bcrp-deficient mice, and AS biliary excretion was negli-
gible. Interestingly, sex-dependent basolateral excretion of AG
(higher in males) and AS (higher in females) was noted in wild-type
mice with a similar trend in Bcrp-deficient mouse livers, reflecting an
increased rate constant for AG formation in male and AS formation in
female mouse livers. In addition, the rate constant for AS basolateral
excretion was increased significantly in female mouse livers com-
pared with that in male mouse livers. It is interesting to note that
multidrug resistance-associated protein 4 was higher in female than
in male mouse livers. In conclusion, sex-dependent differences in
conjugation and transporter expression result in profound differ-
ences in the hepatobiliary disposition of AG and AS in male and
female mouse livers.
Breast cancer resistance protein (BCRP, ABCG2) belongs to the
ATP-binding cassette (ABC) transporter G family and was first
cloned in 1998 from mitoxantrone-resistant cell lines (Doyle et al.,
1998). BCRP is highly expressed in the canalicular membrane of the
hepatocyte as well as in the intestinal epithelia, blood-brain barrier,
and placenta (Robey et al., 2009). BCRP has wide substrate specific-
ity, including organic anions, cations, and zwitterions. BCRP medi-
ates the transport of sulfated hormone metabolites, SN-38, mito-
xantrone, topotecan, doxorubicin, flavopiridol, nitrofurantoin, various
flavonoids, and the chlorophyll metabolite pheophorbide A (Robey et
al., 2001; Jonker et al., 2002, 2005; Nakagawa et al., 2002; Bates et
al., 2004; Imai et al., 2004; Merino et al., 2005a).
Male-predominant expression of Bcrp has been reported in mouse liver
(Merino et al., 2005b; Tanaka et al., 2005). Bcrp is influenced by sex
hormones; estradiol suppresses and testosterone induces Bcrp expression
(Tanaka et al., 2005). Sex-dependent differences in Bcrp expression have
been shown to influence the pharmacokinetics of drugs (Merino et al.,
2005b). For example, the area under the plasma concentration-time curve
of nitrofurantoin in female wild-type mice was 2-fold higher than that
in male mice after oral administration; the cumulative biliary excretion of
nitrofurantoin was 9-fold higher in male than in female mice. In contrast,
no significant sex differences in plasma concentrations or the hepatobili-
ary excretion of nitrofurantoin were observed in Bcrp-deficient mice,
indicating that hepatic Bcrp protein contributes to sex differences in
wild-type mice (Merino et al., 2005b).
The role of various transport proteins in the biliary excretion of
phase II metabolites has been examined using several compounds
including acetaminophen, 4-methylumbelliferone, and harmol, which
are metabolized primarily to glucuronide and sulfate conjugates in
mice (Zamek-Gliszczynski et al., 2006b). In situ single-pass liver
perfusion in male mice demonstrated that Bcrp plays a predominant
role in the biliary excretion of sulfate conjugates, whereas the biliary
excretion of glucuronide conjugates was mediated by both Bcrp and,
to a lesser extent, multidrug resistance-associated protein (Mrp) 2.
Glucuronide and sulfate conjugates of acetaminophen (AG and AS,
respectively) are transported from the hepatocytes into sinusoidal
blood by basolateral transport proteins; Mrp3 mediates basolateral
excretion of AG whereas Mrp3, Mrp4, and other transport proteins
may be involved in the basolateral excretion of AS in mice (Xiong et
al., 2002; Manautou et al., 2005; Zamek-Gliszczynski et al., 2006a).
In the liver, mRNA levels of Mrp4 were higher in female than in male
C57BL/6 mice, but Mrp2 and Mrp3 mRNA levels did not differ based
on gender (Maher et al., 2005). Sex-dependent differences in the
disposition of some phase II conjugates might be anticipated, consid-
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ering the important role of transport proteins in the biliary and
basolateral excretion of phase II conjugates. In addition, these sex-
dependent differences in hepatobiliary disposition may be of potential
clinical relevance, as some sulfate conjugates are important from a
physiologic (e.g., dehydroepiandrosterone sulfate and estrone sulfate)
or pharmacologic (e.g., minoxidil sulfate) standpoint.
The purpose of this study was to examine the influence of Bcrp and sex
on the hepatobiliary disposition of phase II metabolites, using APAP as
a model substrate. In situ single-pass liver perfusion in male and female
wild-type and Bcrp-deficient mice was used to examine the hepatobiliary
disposition of AG and AS. Compartmental pharmacokinetic modeling
was performed to recover relevant parameters governing hepatobiliary
disposition of AG and AS. In light of the physiologic and pharmacologic
roles that some conjugates play in vivo, it is important to investigate the
potential for significant sex-dependent differences in hepatobiliary dis-
position of sulfate and glucuronide metabolites.
Materials and Methods
Materials. APAP, AG, AS, cimetidine, taurocholate, and Krebs-Henseleit
buffer packets were purchased from Sigma-Aldrich (St. Louis, MO). All other
reagents were of analytical grade and were available commercially.
Mice. Male and female C57BL/6 (wild-type) and Abcg2/ (Bcrp-defi-
cient) (created by Deltagen Inc., San Mateo, CA) mice (23–30 g) were a gift
from Eli Lilly and Company (Indianapolis, IN). Further information regarding
background and breeding of these mice has been detailed previously (Nezasa
et al., 2006). All animal procedures were approved by the institutional animal
care and use committee at the University of North Carolina at Chapel Hill.
In Situ Single-Pass Liver Perfusion. Single-pass mouse liver perfusion
studies were performed as described previously (Zamek-Gliszczynski et al.,
2006b). The abdominal cavity of each mouse was opened to expose the
intestines, liver, and gallbladder. The common bile duct above the duodenum
was ligated, and the gallbladder was cannulated with PE-10 tubing (BD
Biosciences, Franklin Lakes, NJ). A loose suture was placed around the
inferior vena cava below the liver. The portal vein was cannulated with a
20-gauge catheter (B. Braun Medical, Inc., Bethlehem, PA), and the liver was
perfused with oxygenated drug-free Krebs-Henseleit buffer containing 5 M
taurocholate at a flow rate of 5 ml/min. The inferior vena cava below the liver
was severed immediately by an incision below the loose suture. Thereafter, the
inferior vena cava above the liver was cannulated with a 20-gauge catheter.
The inferior vena cava below the liver was ligated to direct all perfusate
outflow to the inferior vena cava above the liver. After a 15-min preperfusion
period to equilibrate liver temperature and stabilize bile flow, the liver was
perfused with buffer containing 500 nM APAP for 40 min. Liver perfusion was
continued for an additional 30 min after APAP infusion with drug-free buffer.
Perfusate outflow was collected at designated time points throughout the
70-min experiment. Bile was collected in toto at 10-min intervals. At the end
of the perfusion, livers were isolated and snap-frozen.
Analytical Methods. Perfusate, bile, and liver homogenate samples were
diluted 1:5, 1:250, and 1:10, respectively, to obtain a final sample aliquot of
500 l. Samples were protein-precipitated by the addition of 390 l of ice-cold
methanol containing the internal standard cimetidine. After removal of protein
by centrifugation at 3000g for 15 min at 4°C, the supernatants were analyzed
by liquid chromatography with detection by tandem mass spectrometry (API
4000 triple quadrupole spectrometer with TurboIonSpray interface; Applied
Biosystems Foster City, CA). AS, AG, and the internal standard (cimetidine)
were eluted from an Aquasil C18 column (2.1  50 mm, dp  5 m; Thermo
Fisher Scientific, Waltham, MA) using a mobile phase gradient (A, 0.1%
formic acid in water and B, 0.1% formic acid in methanol; 0–0.75 min hold
at 5% B, 0.75–2.5 min linear gradient to 70% B, 2.5–3.5 min hold at 70% B,
3.5–3.6 min linear gradient to 5% B, and 3.6–4 min hold at 5% B; flow rate,
0.75 ml/min; 0.8–4 min directed to mass spectrometer) and were detected in
negative ion mode using multiple reaction monitoring: AS, 230 3 150 m/z;
AG, 3263 150 m/z; and cimetidine, 2513 157 m/z. Concentrations of APAP
and the internal standard (cimetidine) were quantified using the chromato-
graphic conditions detailed above but were detected in positive ion mode using
multiple reaction monitoring: acetaminophen, 1523 110 m/z; and cimetidine,
2533 117 m/z. Care was taken to confirm that no in-source fragmentation of
the conjugates back to APAP occurred. Standard curves of each analyte
(0.5–1000 nM) were prepared in the appropriate matrices; inter- and intraday
coefficients of variation were 15%.
Western Blot Analysis. Mouse livers, perfused with phosphate-buffered
saline solution, were removed promptly and frozen. Livers were homogenized
with 3 volumes of Tris-HCl solution (pH 7.4) containing complete protease
inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). The homoge-
nates were centrifuged at 1500g for 10 min, and the supernatant was ultracen-
trifuged at 100,000g for 30 min. The resulting pellet was suspended in
Tris-HCl solution (pH 7.4) containing complete protease inhibitor cocktail, 1%
SDS, and 1 mM EDTA. The protein concentration of the solution was deter-
mined with a BCA protein assay reagent kit (Pierce Biotechnology, Rockford,
IL). Bcrp expression was determined using the anti-BCRP primary monoclonal
antibody (BXP-53; Alexis Biochemicals, Carlsbad, CA) at a 1:1000 dilution.
Anti-MRP4 (M4I-10; Alexis Biochemicals) was used at a 1:1000 dilution to
determine the expression of Mrp4. Protein loading was normalized to -actin,
which was detected using a -actin antibody at a dilution of 1:5000 (C4;
Millipore Bioscience Research Reagents, Temecula, CA). Immunoreactive
protein bands were detected by chemiluminescence using a VersaDoc imaging
system (Bio-Rad, Hercules, CA), and densitometry analysis was performed
using the Quantity One software package (version 4.1; Bio-Rad).
Pharmacokinetic Modeling. A compartmental modeling approach was used
to describe the hepatobiliary disposition of APAP and metabolites in perfused
livers from male and female wild-type and Bcrp-deficient mice and to recover
estimates of key pharmacokinetic parameters. AG and AS outflow perfusate
and biliary excretion rates were calculated as the product of flow (perfusate or
bile) and outflow perfusate or biliary concentrations, respectively, during each
collection period and then were normalized to liver weight. Several structurally
distinct models were evaluated; standard model selection criteria including
residual distribution and Akaike’s information criterion were used to identify
the optimal structure. The compartmental model that best described the data is
shown in Fig. 1. Differential equations derived from the model scheme in Fig.
1 were as follows (initial conditions were denoted with a superscript zero):
dXAPAP
dt
 CLup  Cin  XAPAP  (Kperf,APAP 
Kgluc  Ksulf); XAPAP
0  0; t  40 min
dXAPAP
dt
 XAPAP  (Kperf,APAP  Kgluc  Ksulf); t  40 min
dXAG1
dt
















 Q  Cin  CLup  Cin  XAPAP  Kperf,APAP; t  40 min
dXperfusate,APAP
dt
 XAPAP  Kperf,APAP; t  40 min
dXperfusate,AG
dt
 XAG1  Kperf,AG
dXperfusate,AS
dt
 XAS1  Kperf,AS
dXbile,AG
dt
 XAG2  Kbile,AG
dXbile,AS
dt
 XAS2  Kbile,AS
1917SEX-DEPENDENT HEPATIC DISPOSITION OF APAP METABOLITES
The final model included compartments representing hepatocellular spaces
for APAP, AG, and AS. To describe the prolonged biliary excretion of AG and
AS after APAP washout relative to basolateral excretion of AG and AS, an
intervening compartment between the site of conjugate formation and the bile
compartment was included in the model. This intervening compartment was
required to describe disposition of AG in all livers and of AS in wild-type but
not in Bcrp-deficient mouse livers (AS biliary concentrations measured in
Bcrp-deficient mouse livers were below the limit of quantitation of the assay).
Differential equations describing substrate flux in each compartment were fit
simultaneously to the perfusate and biliary excretion rate data by nonlinear
least-squares regression (WinNonlin Pro version 4.2; Pharsight, Mountain
View, CA) with a weighting scheme of 1/(Y predicted). The precision of
parameter estimates was maximized with stepwise nonlinear least-squares
regression. AG perfusate and biliary excretion rate data from male and female
wild-type and Bcrp-deficient mouse livers were used to estimate Kperf, AG, Kg1,
and Kbile, AG, whereas CLup, Kperf, APAP, Kgluc, and Ksulf were held constant at
the estimated values. Likewise, AS perfusate and biliary excretion rate data
were used to estimate Kperf, AS, Ks1, and Kbile, AS, whereas CLup, Kperf, APAP,
Kgluc, and Ksulf were held constant at the estimated values.
Data Analysis. All data are expressed as the mean  SD unless otherwise
indicated. The effects of Bcrp expression (wild-type or Bcrp-deficient) and sex
(male or female) were assessed using a two-way analysis of variance. Data
shown in Table 1 and Figs. 3 and 4 were analyzed further with a Bonferroni
post hoc test, but no further analysis was performed for the pharmacokinetic
parameter estimates shown in Table 2. An unpaired Student’s t test was used
to determine the statistical significance of differences in AS biliary excretion
from male and female mouse livers because AS biliary excretion was negli-
gible in Bcrp-deficient mice. Differences were considered to be statistically
significant when p  0.05.
Results
Statistically significant differences were observed in body weights
among male and female wild-type mice, but mouse liver weights
normalized for body weight were comparable between wild-type and
Bcrp-deficient male and female mice (Table 1). Outflow perfusate
concentrations of APAP reached a plateau within 20 min of contin-
uous perfusion (Fig. 2). The hepatic extraction ratios of APAP,
calculated from inflow and outflow APAP perfusate concentrations
between 30 and 40 min of perfusion, ranged from 24.8 to 35.4%
among mouse groups (Table 1). Because APAP, AG, and AS con-
centrations in liver homogenates after the 30-min washout phase were
negligible, total recovery (% of dose) was calculated by adding
recovered APAP, AG, and AS in outflow perfusate and bile; in all
cases, total recovery was comparable among all mouse groups
(Table 1).
Biliary excretion of AG in livers from male wild-type mice was
2.5-fold higher than that in female wild-type mouse livers, but AG
biliary excretion between male and female Bcrp-deficient mice was
comparable (Fig. 3A). Relative to the corresponding wild-type mouse
livers, biliary excretion of AG was decreased 73 and 54% in male
and female Bcrp-deficient mouse livers, respectively. Cumulative AG
excretion in outflow perfusate from male wild-type and Bcrp-deficient
livers was 1.6-fold higher than that from female wild-type and
Bcrp-deficient livers (Fig. 3B).
Biliary excretion of AS in livers from male wild-type mice was
2.2-fold higher than that from female wild-type livers (Fig. 4A). In
Bcrp-deficient mice, AS biliary recovery was negligible. AS basolat-
eral excretion in female wild-type and Bcrp-deficient mouse livers
was 3.1- and 2.4-fold higher, respectively, than that in livers from
their male counterparts (Fig. 4B).
Immunoblot analysis was performed with crude membrane frac-
tions of liver homogenates from male and female wild-type and
Bcrp-deficient mice to compare the levels of Bcrp and Mrp4 protein
TABLE 1
Mouse body weights, liver weights normalized to body weight, APAP extraction ratio, and total recovery at 70 min in in situ single-pass perfused livers from male
and female wild-type and Bcrp-deficient mice
Livers were perfused with Krebs-Henseleit buffer containing 500 nM APAP for 40 min followed by an additional 30-min infusion with drug-free buffer. Data are the mean  S.D. (n 
3–4/group).
Wild-Type Bcrp-Deficient
Male Female Male Female
Body weight (g) 28.4  0.8* 25.8  1.8* 25.9  1.7 24.5  1.7
Liver weight/body weight (%) 4.7  0.2 4.8  0.5 4.3  0.2 4.4  0.7
Extraction ratio (%) 35.4  4.8 29.6  7.1 30.8  6.1 24.8  1.2
Total recovery (% of dose) 98.4  5.2 91.7  8.5 93.6  3.7 98.2  4.8
* Groups denoted with an asterisk were significantly different, p  0.05.
FIG. 1. Model scheme depicting the hepatic disposition
of APAP, AG, and AS in the single-pass perfused
mouse liver. Q, flow rate; Cin, concentration of APAP
in inflow perfusate; Cout, concentration of APAP in
outflow perfusate; XAPAP, amount of APAP in liver
compartment; XAG-1 and XAG-2, amount of AG in liver
compartments 1 and 2, respectively; XAS-1 and XAS-2,
amount of AS in liver compartments 1 and 2, respec-
tively; CLup, uptake clearance into the liver; Kperf, APAP,
first-order rate constant for basolateral excretion of
APAP; Kperf, AG, first-order rate constant for basolateral
excretion of AG; Kperf, AS, first-order rate constant for
basolateral excretion of AS; Kgluc and Ksulf, first-order
rate constants for formation of AG and AS, respec-
tively; Kg1, first-order rate constant for movement of
AG from hepatic compartment 1 to 2; Ks1, first-order
rate constant for movement of AS from hepatic com-
partment 1 to 2; and Kbile, AG and Kbile, AS, first-order
rate constants for biliary excretion of AG and AS,
respectively. AS biliary excretion was lower than the
limit of quantitation in Bcrp-deficient mouse livers.
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(Fig. 5). As reported previously (Tanaka et al., 2005), densitometry
analysis revealed that hepatic Bcrp protein, normalized to the -actin
signal, was 3-fold higher in male wild-type mice than in female
wild-type mice. Interestingly, there was a trend toward increased
hepatic Mrp4 protein in females; Mrp4 protein, normalized to the
-actin signal, in female wild-type and Bcrp-deficient mouse livers
was 3.5- and 1.6-fold higher than that in male mouse livers from
wild-type and Bcrp-deficient mice, respectively.
The model scheme presented in Fig. 1 best described the current
experimental data. Representative fits of the model to APAP, AG, and
AS biliary and basolateral excretion rate versus time data are shown
in Fig. 6. Pharmacokinetic parameter estimates obtained by resolving
the differential equations representing biliary and basolateral excre-
tion rate versus time data for APAP, AG, and AS are presented in
Table 2. The uptake clearance (CLup) was comparable with the
perfusate flow rate (Q; 5 ml/min). The rate constant for APAP
basolateral excretion (Kperf, APAP) was comparable among male and
female wild-type and Bcrp-deficient mouse livers. Sex-dependent
differences in metabolite formation rate constants were observed; the
rate constant for AG formation (Kgluc) was 2-fold higher in male
mouse livers, and the rate constant for AS formation (Ksulf) was 2
to 4-fold higher in female mouse livers. The basolateral excretion rate
constant of AS (Kperf, AS), but not that of AG (Kperf, AG), differed
based on sex; the AS basolateral excretion rate constant was 2-fold
higher in female versus male mouse livers. The AG biliary excretion
rate constant (Kbile, AG) was higher in male than in female wild-type
mouse livers (0.014 versus 0.002 min1) but was similar between
male and female Bcrp-deficient mouse livers. The rate constant for
movement of AS from hepatic compartment 1 to 2 (Ks1) was higher
in male than in female wild-type mouse livers. Likewise, the rate
constant for AS biliary excretion (Kbile, AS) was higher in male versus
female wild-type mouse livers (0.107 versus 0.043 min1).
Discussion
The current studies support the hypothesis that sex-dependent he-
patic Bcrp expression influences the hepatobiliary disposition of sul-
fate and glucuronide conjugates of the model substrate APAP during
in situ single-pass mouse liver perfusion. Male-predominant Bcrp
protein expression in wild-type mouse livers is consistent with 2.5-
fold higher biliary excretion of AG and AS in male than in female
wild-type mouse livers. Sex-dependent differences in biliary excretion
of AG were not observed in Bcrp-deficient mice. Pharmacokinetic
modeling revealed that the rate constants governing AG and AS
biliary excretion were significantly higher in male than in female
wild-type mouse livers. AS biliary excretion was negligible and AG
biliary excretion rate constants were markedly reduced in Bcrp-
deficient mice, consistent with recent findings demonstrating an im-
portant role of Bcrp in AG and AS biliary excretion in male mice
(Zamek-Gliszczynski et al., 2006b). Both Bcrp and Mrp2 seem to be
involved in AS biliary excretion in rats (Zamek-Gliszczynski et al.,
FIG. 2. APAP concentrations (nanomolar) in outflow perfusate from male wild-
type (F) and Bcrp-deficient (E) and female wild-type () and Bcrp-deficient (‚)
mouse liver perfusions. Livers were perfused with Krebs-Henseleit buffer contain-
ing 500 nM APAP for 40 min followed by an additional 30-min infusion with
drug-free buffer. (n  3–4/group).
FIG. 3. Cumulative biliary excretion and
basolateral excretion of AG (A and B, re-
spectively; nanomoles per gram of liver) in
male and female wild-type and Bcrp-defi-
cient perfused mouse livers through 70 min
as described in the legend to Fig. 2 (n 
3–4/group; , groups denoted with an as-
terisk were significantly different, p 
0.05).
FIG. 4. Cumulative biliary excretion and
basolateral excretion of AS (A and B, re-
spectively; nanomoles per gram of liver) in
male and female wild-type and Bcrp-defi-
cient perfused mouse livers through 70 min
as described in the legend to Fig. 2 (n 
3–4/group; , groups denoted with an as-
terisk were significantly different, p 
0.05). N.D., not detected.
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2005); however, AS biliary excretion was not decreased in Mrp2-
deficient mice (Zamek-Gliszczynski et al., 2006b). This apparent
discrepancy in the mechanisms of AS biliary excretion may be due to
species-specific differences in the affinity of multiple hepatic efflux
proteins for AS.
It is interesting to note that sex differences were observed for
basolateral excretion of AG and AS, with more extensive basolateral
excretion of AG in male and more extensive AS basolateral excretion
in female mouse livers (Figs. 3B and 4B). One possible explanation
for these findings is that the rate constant governing AG formation
(Kgluc) was greater in male mouse livers, whereas the rate constant for
AS formation (Ksulf) was greater in female mouse livers, suggesting
sex-dependent differences in formation of AG and AS. Although the
primary isoforms of UDP-glucuronosyltransferases (Ugt) and sulfo-
transferases (Sult) responsible for AG and AS formation in mice
remain to be elucidated, previously published data demonstrate male-
predominant mRNA expression of Ugt1a5 and female-predominant
mRNA expression of Sult1a1 and Sult2a1/2 in mouse livers (Alnouti
and Klaassen, 2006; Buckley and Klaassen, 2007). In human liver
microsomes, protein expression of UGT1A6, a major isoform respon-
sible for AG formation, was 50% higher in males than in females
(Court et al., 2001).
Sex-dependent basolateral excretion of AG and AS also may be due
to differences in the expression of transport protein(s) responsible for
AG and AS basolateral excretion. As reported previously, Mrp3 plays
a significant role in basolateral excretion of AG, whereas both Mrp3
and Mrp4, as well as other unidentified mechanisms, may be involved
in AS basolateral excretion (Xiong et al., 2002; Manautou et al., 2005;
Zamek-Gliszczynski et al., 2006a). Previous studies showed moderate
expression of Mrp3 mRNA in mouse livers, but no differences in
Mrp3 mRNA were noted between male and female mouse livers
(Maher et al., 2005). In the current study, pharmacokinetic modeling
revealed that the rate constants for AG basolateral excretion between
male and female mouse livers were not different. Thus, greater AG
basolateral excretion in male versus female mouse livers appears to be
due primarily to more extensive glucuronidation in male mouse livers.
In contrast, the rate constant governing AS basolateral excretion
(Kperf, AS) was significantly higher in female versus male mouse
livers; this finding cannot be explained by increased AS formation in
female mice. It is interesting to note that Western blot analysis
demonstrated greater Mrp4 protein in crude membrane fractions from
female than from male mouse livers, consistent with previous findings
that hepatic Mrp4 mRNA was increased in female compared with
male wild-type mice (Maher et al., 2005). This sex-dependent increase
in Mrp4 protein levels, coupled with more extensive sulfation in
female mouse livers, may explain, in part, the higher AS basolateral
excretion in female mouse livers because Mrp4 has been implicated in
the basolateral excretion of AS (Lickteig et al., 2007).
The pharmacokinetic model included an intervening compartment
FIG. 5. Representative immunoblot of Bcrp, Mrp4, and actin in crude membrane
fractions from male and female wild-type and Bcrp-deficient mouse liver homog-
enates from three independent experiments (30 g protein/well).
FIG. 6. Representative outflow perfusate rate (picomoles per minute per gram of
liver) of AG (F) and AS (f) and biliary excretion rate (picomoles per minute per
gram of liver) of AG (E) and AS () in male and female wild-type and Bcrp-
deficient mouse livers. Livers were perfused with Krebs-Henseleit buffer containing
500 nM APAP for 40 min followed by an additional 30-min infusion with drug-free
buffer. Curves represent the best fit of the model scheme depicted in Fig. 1 to the
data.
TABLE 2
Mean pharmacokinetic parameter estimates governing APAP, AG, and AS
disposition in in situ single-pass perfused livers from wild-type and Bcrp-
deficient male and female mice
n  3–4/group.
Parameter
Mean Estimates (CV %)
Wild-Type Brcp-Deficient
CLup (ml/min)
Male 5.63 (12.1) 5.60 (13.2)
Female 5.79 (4.9) 5.55 (8.8)
Kperf, APAP (min
1)
Male 0.468 (16.5) 0.588 (44.7)
Female 0.525 (31.1) 0.564 (36.3)
Kgluc (min
1)*
Male 0.183 (36.9) 0.199 (17.3)
Female 0.121 (16.5) 0.119 (8.2)
Ksulf (min
1)*
Male 0.007 (13.1) 0.009 (50.6)
Female 0.026 (8.8) 0.018 (44.6)
Kperf, AG (min
1)
Male 0.168 (45.4) 0.247 (22.5)
Female 0.217 (49.3) 0.214 (77.3)
Kg1 (min
1)
Male 0.044 (89.3) 0.104 (36.7)
Female 0.093 (49.4) 0.092 (55.3)
Kbile, AG (min
1)*, **
Male 0.014 (45.4) 0.001 (66.4)
Female 0.002 (68.1) 0.001 (72.1)
Kperf, AS (min
1)*
Male 0.379 (38.6) 0.271 (11.7)
Female 0.663 (17.6) 0.634 (9.6)
Ks1 (min
1)*
Male 0.048 (25.3) N.A.
Female 0.017 (39.5) N.A.
Kbile, AS (min
1)*
Male 0.107 (8.0) N.A.
Female 0.043 (72.6) N.A.
CV, coefficient of variation; N.A., not available.
* p  0.05, male vs. female.
** p  0.05, wild-type vs. Bcrp-deficient mice.
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between the sites of conjugate formation and excretion into bile. This
additional compartment was required to describe the prolonged biliary
excretion of AG and AS during the washout phase (Fig. 1). Movement
of AG and AS from the site of conjugate formation to the site of
biliary excretion was best described as a unidirectional rather than
bidirectional process, based on markedly lower coefficients of varia-
tion associated with this model fit. Likewise, pharmacokinetic mod-
eling of the in vivo disposition of APAP and AG in rats has suggested
the existence of a discrete cytosolic compartment before AG biliary
excretion (Studenberg and Brouwer, 1993). In a study of hepatic
intracellular distribution of several compounds, the presence of a
cytosolic link between metabolite formation and subsequent biliary
excretion also was proposed (Levine and Singer, 1972). Kipp et al.
(2001) demonstrated that newly synthesized canalicular transport pro-
teins (e.g., P-glycoprotein) may be directly trafficked from the Golgi
apparatus to the apical membrane, or they may be stored transiently in
intracellular compartments before apical delivery to the membrane
(e.g., bile salt export pump); taurocholate or dibutyryl cAMP can
stimulate trafficking of bile salt export pump and P-glycoprotein.
Phosphatidylinositol 3-kinase is involved in the vesicular trafficking
of ABC transporters (Misra et al., 1999). Of note, the phosphatidyl-
inositol 3-kinase inhibitor LY294002 translocated Bcrp1 from the
plasma membrane to the cytoplasmic compartment in side population
cells from mice (Mogi et al., 2003). AG and AS may bind or associate
with subcellularly localized ABC transport proteins in mouse liver
before biliary excretion, as described by intrahepatic compartments in
the current pharmacokinetic model.
In summary, the present study demonstrated sex-dependent hepa-
tobiliary disposition of glucuronide and sulfate conjugates of APAP in
mice due to differences in hepatic transport protein expression and
conjugation. In light of the extensive use of the mouse as a model
species to examine hepatobiliary drug disposition and drug-induced
liver injury, such sex-dependent differences in transport proteins and
phase II conjugation may explain different outcomes between male
and female mice during preclinical drug development.
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